← Open Payments lookup

BRYAN SAUTER: Open Payments

NPI 1407944820 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,443 in 107 payments from 23 companies in 2025. Trend: 2023 $1,331 · 2024 $2,258 · 2025 $3,443

Food & beverage: $2,768Consulting: $675
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$1,079
ABBVIE INC.23$419
Madrigal Pharmaceuticals11$406
Janssen Biotech, Inc.17$405
Phathom Pharmaceuticals, Inc.7$163
Takeda Pharmaceuticals U.S.A., Inc.10$143
GENZYME CORPORATION3$121
Boston Scientific Corporation1$114
Aimmune Therapeutics, Inc.1$91
Ardelyx, Inc.2$90

Products named: XIFAXAN, REZDIFFRA, TREMFYA, DUPIXENT, VOQUEZNA, RINVOQ, CREON, LINZESS.

Industry payments across CA — which companies pay providers there.